Skip to main content
PetMed Express, Inc. (PETS)
NASDAQ: PETS · Real-Time Price · USD
4.970
-0.130 (-2.55%)
At close: Dec 20, 2024, 4:00 PM
4.870
-0.100 (-2.01%)
After-hours: Dec 20, 2024, 5:39 PM EST

PetMed Express Revenue

PetMed Express had revenue of $59.57M in the quarter ending September 30, 2024, a decrease of -16.10%. This brings the company's revenue in the last twelve months to $259.34M, down -4.08% year-over-year. In the fiscal year ending March 31, 2024, PetMed Express had annual revenue of $281.06M with 9.54% growth.

Revenue (ttm)
$259.34M
Revenue Growth
-4.08%
P/S Ratio
0.39
Revenue / Employee
$903,634
Employees
287
Market Cap
102.55M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024281.06M24.49M9.54%
Mar 31, 2023256.58M-15.70M-5.77%
Mar 31, 2022272.28M-31.30M-10.31%
Mar 31, 2021303.58M19.46M6.85%
Mar 31, 2020284.13M706.00K0.25%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Quipt Home Medical 245.92M
MDxHealth 84.71M
Champions Oncology 53.57M
Tonix Pharmaceuticals Holding 11.29M
X4 Pharmaceuticals 1.12M
Revenue Rankings

PETS News

More News